Correlation Between Summit Therapeutics and Tarsus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Summit Therapeutics and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Tarsus Pharmaceuticals.

Diversification Opportunities for Summit Therapeutics and Tarsus Pharmaceuticals

-0.57

Correlation Coefficient

Summit Therapeutics  Tarsus Pharmaceuticals

Excellent diversification

The 3 months correlation between Summit and Tarsus is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Summit Therapeutics and Tarsus Pharmaceuticals

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 2.03 times more return on investment than Tarsus Pharmaceuticals. However, Summit Therapeutics is 2.03 times more volatile than Tarsus Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.14 per unit of risk. If you would invest  790.00  in Summit Therapeutics PLC on October 13, 2024 and sell it today you would earn a total of  995.00  from holding Summit Therapeutics PLC or generate 125.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Summit Therapeutics PLC  vs.  Tarsus Pharmaceuticals

Summit Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Tarsus Pharmaceuticals

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Summit Therapeutics and Tarsus Pharmaceuticals

The main advantage of trading using opposite Summit Therapeutics and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.

The idea behind Summit Therapeutics PLC and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.